Obstetrics and Gynecology

1046 questions

Question 161Question →

During a routine wellness check, a patient reports noticing small amounts of dark blood on her toilet tissue over the past week. Review of her medical record confirms she is nulliparous, has a body mass index of 34 kg/m234 \text{ kg/m}^2, and experienced her final menstrual period eight years ago. A pelvic examination reveals a small amount of blood in the vaginal vault with a visually normal cervix and no vaginal lacerations. Which of the following is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Perform an endometrial biopsy

Answer

Perform an endometrial biopsy
The correct approach for any patient with postmenopausal bleeding is to immediately rule out endometrial cancer. This patient also possesses significant risk factors, including obesity (which increases the peripheral conversion of androgens to estrogens in adipose tissue) and nulliparity, both of which lead to prolonged unopposed estrogen exposure. Performing an endometrial biopsy provides a direct tissue sample to check for hyperplasia or carcinoma and is an unequivocally appropriate first step in management.

Step-by-Step Solution

1
Identify the primary clinical problem
The patient is presenting with postmenopausal bleeding and has significant risk factors for endometrial cancer (obesity and nulliparity).
Recognizing the high-risk nature of postmenopausal bleeding dictates the urgency and type of the clinical workup.
2
Determine the required diagnostic pathway
Postmenopausal bleeding requires direct evaluation of the endometrium to rule out malignancy.
Endometrial cancer must be excluded in any postmenopausal woman presenting with vaginal bleeding.
3
Select the most appropriate initial diagnostic intervention
An endometrial biopsy is selected as the best next step.
Endometrial biopsy provides a histological diagnosis and is a first-line diagnostic standard for this presentation.

Key Concept

Any vaginal bleeding in a postmenopausal woman must be thoroughly investigated with an endometrial biopsy or transvaginal ultrasound to definitively rule out endometrial carcinoma.
Question 162Question →

A 59-year-old woman comes to the office due to a 3-month history of continuous urinary dribbling. She says, "I never feel like my bladder is fully empty, and urine just constantly leaks out all day." She has a 20-year history of type 2 diabetes mellitus that is poorly controlled, with a recent hemoglobin A1c of 9.2%. Her current medications include metformin, glipizide, and insulin glargine. On pelvic examination, the vaginal mucosa is pink and well-rugated, and there is no evidence of pelvic organ prolapse. Neurologic examination shows decreased sensation to monofilament testing over the plantar surface of both feet. Which of the following is the most appropriate next step in the evaluation of this patient's urinary symptoms?

Show answer & explanation

Answer: Measurement of postvoid residual volume

Answer

Measurement of postvoid residual volume
This patient's continuous urinary dribbling, sensation of incomplete emptying, and long-standing poorly controlled diabetes with peripheral neuropathy strongly suggest overflow incontinence due to a neurogenic bladder (detrusor underactivity). The initial and most appropriate step in evaluating suspected overflow incontinence is measuring the postvoid residual (PVR) volume, typically using a non-invasive bladder ultrasound. A high PVR (usually >150-200 mL) confirms urinary retention.

Step-by-Step Solution

1
Identify the type of urinary incontinence based on the clinical presentation.
The patient has continuous urinary dribbling, a sensation of incomplete emptying, and diabetic peripheral neuropathy, which collectively represent the classic presentation of overflow incontinence.
Accurate clinical diagnosis of the underlying incontinence mechanism is required to guide safe and effective further testing.
2
Determine the most appropriate initial diagnostic test for suspected overflow incontinence.
Measurement of postvoid residual (PVR) volume.
PVR safely and non-invasively confirms the presence of urinary retention (incomplete bladder emptying) and establishes the diagnosis before considering management.

Key Concept

Diagnosis of overflow incontinence
Question 163Question →

Match each clinical vignette describing an adverse reaction during the management of postpartum hemorrhage to the underlying mechanism of action of the responsible pharmacologic agent.

Click a left item, then click its matching right item

Items

A 29-year-old woman with uterine atony develops severe wheezing, dyspnea, and oxygen desaturation to 88% immediately after intramuscular administration of a uterotonic agent.
A 34-year-old woman with chronic hypertension receives a second-line medication for postpartum hemorrhage and subsequently experiences a severe hypertensive crisis (190/115 mmHg) and a throbbing headache.
A 26-year-old woman receiving a prolonged, high-dose intravenous infusion of a first-line uterotonic agent develops lethargy, confusion, and a generalized tonic-clonic seizure associated with a serum sodium level of 116 mEq/L.
A 31-year-old woman treated for refractory postpartum hemorrhage complains of severe, sudden-onset diarrhea, nausea, and a transient fever of 38.6°C (101.5°F) shortly after rectal administration of a uterotonic.

Matches

Show answer & explanation

Answer

The left clinical vignettes match to their right pharmacologic mechanisms as follows: wheezing matches the PGF2-alpha analog, hypertension matches the ergot alkaloid, hyponatremia matches the nonapeptide hormone analog, and diarrhea/fever matches the PGE1 analog.
Each uterotonic agent has a distinct mechanism of action corresponding directly to its side effect profile. Carboprost (PGF2-alpha) causes bronchospasm. Methylergonovine (ergot alkaloid) causes vasoconstriction and systemic hypertension. Oxytocin (ADH analog) causes water retention and subsequent hyponatremia. Misoprostol (PGE1) causes GI stimulation and fever.

Step-by-Step Solution

1
Analyze the first vignette describing respiratory distress after an intramuscular uterotonic.
Identified as carboprost-induced bronchospasm.
Carboprost is a prostaglandin F2-alpha analog known to cause smooth muscle constriction in both the uterus and airways.
2
Analyze the second vignette describing a hypertensive crisis and headache after uterotonic administration.
Identified as methylergonovine-induced hypertension.
Methylergonovine is an ergot alkaloid that causes potent peripheral vasoconstriction.
3
Analyze the third vignette describing seizures and hyponatremia during a prolonged intravenous infusion.
Identified as oxytocin-induced water intoxication.
Oxytocin is a nonapeptide structurally similar to ADH, causing cross-reactivity at V2 receptors leading to dilutional hyponatremia.
4
Analyze the fourth vignette describing diarrhea and fever after rectal administration.
Identified as misoprostol-induced GI distress and pyrexia.
Misoprostol is a PGE1 analog that stimulates gastrointestinal smooth muscle and alters temperature regulation.

Key Concept

Pharmacologic mechanisms and characteristic adverse effects of uterotonic agents used in postpartum hemorrhage
Estimated Time:1m 30s
Question 164Question →

An academic medical center runs a specialized complex contraception clinic. Four patients present seeking highly effective, reversible contraception. Match each patient's presentation and medical history with the single most appropriate contraceptive method based on the World Health Organization Medical Eligibility Criteria (WHO MEC) and potential secondary clinical benefits.

Click a left item, then click its matching right item

Items

A 31-year-old woman with epilepsy taking carbamazepine presents with severe fatigue. Urine beta-hCG is negative. Laboratory studies show a hemoglobin of 9.2 g/dL9.2 \text{ g/dL}. She reports heavy menstrual bleeding saturating 66 to 88 pads daily. Vital signs and pelvic examination are normal.
A 38-year-old woman with a history of unprovoked deep vein thrombosis 33 years ago and Roux-en-Y gastric bypass 11 year ago (current BMI 26 kg/m226 \text{ kg/m}^2). Urine beta-hCG is negative. Ultrasound confirms a 6-cm6\text{-cm} submucosal leiomyoma significantly distorting the endometrial cavity.
A 34-year-old woman presents 66 months after surgical resection of an estrogen receptor-positive ductal carcinoma in situ. She is currently taking tamoxifen and is amenorrheic. Serum beta-hCG is negative. Physical examination shows no pelvic masses or abnormalities.
A 28-year-old woman with homozygous sickle cell disease experiences frequent vaso-occlusive pain crises requiring hospitalization. Urine beta-hCG is negative. Vital signs are stable. She strongly desires a method that might provide secondary disease-modifying benefits.

Matches

Show answer & explanation

Answer

The epilepsy patient matches with the Levonorgestrel-releasing intrauterine device. The patient with prior DVT, gastric bypass, and a distorted cavity matches with the Subdermal etonogestrel implant. The breast cancer patient matches with the Copper-releasing intrauterine device. The sickle cell disease patient matches with the Depot medroxyprogesterone acetate injection.
Each clinical profile maps uniquely to one contraceptive method based on overlapping WHO MEC guidelines. The epilepsy patient requires a method unaffected by CYP inducers that also controls bleeding (LNG-IUD). The complex bariatric/fibroid patient requires a non-oral, non-estrogen, non-intrauterine method (Implant). The breast cancer patient must avoid all hormones completely (Copper IUD). The sickle cell patient derives unique hematologic benefits from DMPA.

Step-by-Step Solution

1
Evaluate eligibility for the patient with epilepsy, carbamazepine use, and heavy menstrual bleeding.
Identify the Levonorgestrel-releasing intrauterine device as the optimal choice.
CYP450 inducers like carbamazepine lower the efficacy of systemic hormones. The LNG-IUD is unaffected (MEC 1) and uniquely treats her symptomatic heavy bleeding.
2
Evaluate eligibility for the patient with a prior DVT, Roux-en-Y bypass, and a submucosal fibroid.
Identify the Subdermal etonogestrel implant as the optimal choice.
Estrogen is strictly contraindicated due to DVT (MEC 4). Malabsorption from gastric bypass reduces oral pill efficacy (MEC 3). The distorted cavity prevents IUD placement (MEC 4). The implant safely addresses all constraints.
3
Evaluate eligibility for the patient with estrogen receptor-positive breast cancer taking tamoxifen.
Identify the Copper-releasing intrauterine device as the optimal choice.
Active or recent breast cancer strictly contraindicates all hormonal methods (MEC 4). Only hormone-free methods, such as the highly effective copper IUD, are safe.
4
Evaluate eligibility for the patient with sickle cell disease and frequent crises.
Identify the Depot medroxyprogesterone acetate injection as the optimal choice.
DMPA provides excellent contraception and uniquely offers secondary disease-modifying benefits by significantly reducing the frequency of vaso-occlusive sickle cell crises.

Key Concept

Integration of the WHO Medical Eligibility Criteria (MEC) across complex patient profiles, emphasizing drug interactions, anatomical constraints, oncologic contraindications, and secondary non-contraceptive benefits.
Question 165Question →

A 68-year-old woman presents to the clinic reporting recurrent, light vaginal bleeding for the past 4 months. Three months ago, she was evaluated at an outside facility for the initial onset of this symptom. At that time, a transvaginal ultrasound was performed, demonstrating a homogeneous endometrial stripe of 2.6 mm and normal-appearing ovaries. A Pap test was negative for intraepithelial lesion or malignancy. She was diagnosed with genitourinary syndrome of menopause and prescribed vaginal estrogen therapy. The patient has been using the estrogen cream twice weekly as directed, but reports that the intermittent spotting has persisted. She takes no other medications and has no history of abnormal Pap smears. Vital signs are within normal limits. Pelvic examination reveals a well-rugated, moist vaginal mucosa. The cervix appears nulliparous and grossly normal, with a small amount of dark blood noted at the external os. The uterus is small, mobile, and non-tender, with no palpable adnexal masses. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Endometrial biopsy

Answer

Endometrial biopsy
In a postmenopausal woman, any vaginal bleeding is considered abnormal and warrants investigation for endometrial cancer. The initial evaluation can involve either a transvaginal ultrasound or an endometrial biopsy. If an ultrasound is chosen and demonstrates an endometrial stripe of 4 mm or less, the risk of malignancy is exceedingly low (< 1%), and observation is reasonable if the bleeding resolves. However, if the bleeding is persistent or recurrent, tissue sampling is strictly required. This is because Type II endometrial cancers (such as serous or clear cell carcinomas) are estrogen-independent, arise in atrophic endometrium, and frequently present with an endometrial thickness of less than 4 mm. Therefore, despite the previously reassuring ultrasound and the concurrent use of vaginal estrogen, this patient's persistent bleeding mandates an endometrial biopsy.

Step-by-Step Solution

1
Analyze the patient's clinical presentation and timeline of symptoms.
The patient is a postmenopausal woman with persistent vaginal bleeding despite a prior reassuring ultrasound (endometrial stripe < 4 mm) and appropriate treatment for vaginal atrophy.
Establishing the sequence of evaluations determines if the standard initial algorithm has already been exhausted.
2
Evaluate the reliability of the prior transvaginal ultrasound.
While an endometrial stripe of 4 mm or less generally confers a < 1% risk of malignancy, it is not an absolute guarantee of benignity.
Standard guidelines state that observation is only appropriate if the bleeding stops after a reassuring ultrasound.
3
Identify the underlying pathological risk factor for this specific presentation.
Type II endometrial carcinomas (e.g., papillary serous, clear cell) are estrogen-independent, can arise from an atrophic endometrium, and frequently present with an endometrial thickness of less than 4 mm.
Understanding the pathogenesis of Type II cancers explains why the 'thin stripe' rule has exceptions.
4
Determine the definitive next step in management.
Tissue sampling is mandatory to rule out malignancy.
Persistent postmenopausal bleeding overrides previous reassuring imaging, making an endometrial biopsy the required next step.

Key Concept

In postmenopausal bleeding, persistent symptoms despite an initial transvaginal ultrasound showing an endometrial stripe <= 4 mm mandate an endometrial biopsy to rule out Type II endometrial carcinoma.
Question 166Question →

A 28-year-old nulligravid woman presents to the clinic alongside her partner, reporting an inability to conceive after 12 months of regular, unprotected intercourse. She previously experienced predictable 28-day menstrual cycles, but over the past eight months, she has had only two episodes of light vaginal bleeding. The patient notes a generalized lack of energy and an unintentional 8-kg (17.6-lb) weight gain during this period. She also reports the recent appearance of dark, coarse hair on her chin. Her body mass index is 31 kg/m 2^2. Vital signs show a heart rate of 56/min and blood pressure of 112/74 mmHg. Pelvic examination is unremarkable. Transvaginal ultrasonography reveals symmetrically enlarged ovaries, each containing 15 to 20 small subcapsular follicles.

Laboratory studies show the following:
- β\beta-hCG: negative
- Total testosterone: 65 ng/dL (Reference: 15-70 ng/dL)
- Prolactin: 48 ng/mL (Reference: < 20 ng/mL)
- Thyroid-stimulating hormone (TSH): 11.2 μ\mu U/mL (Reference: 0.4-4.0 μ\mu U/mL)
- Free thyroxine (T4): 0.6 ng/dL (Reference: 0.9-1.7 ng/dL)
- Follicle-stimulating hormone (FSH): 4 mIU/mL
- Luteinizing hormone (LH): 3 mIU/mL

Which of the following is the most appropriate next step in the management of this patient's infertility?

Show answer & explanation

Answer: Initiate levothyroxine supplementation

Answer

Initiate levothyroxine supplementation
The correct answer is to initiate levothyroxine supplementation. This patient has primary hypothyroidism, evidenced by an elevated TSH and low free T4. Primary hypothyroidism can perfectly mimic Polycystic Ovary Syndrome (PCOS). The lack of thyroid hormone negative feedback causes the hypothalamus to increase thyrotropin-releasing hormone (TRH) secretion. TRH acts on the anterior pituitary to stimulate not only TSH but also prolactin. The resulting mild hyperprolactinemia suppresses gonadotropin-releasing hormone (GnRH) pulsatility, leading to hypogonadotropic hypogonadism, amenorrhea, and anovulatory infertility. Furthermore, hypothyroidism reduces the hepatic synthesis of sex hormone-binding globulin (SHBG). This leads to an increase in free, biologically active testosterone, which causes clinical hirsutism even when total testosterone is within the normal reference range. Finally, the chronic anovulation results in the polycystic ovarian morphology observed on ultrasound. Because her entire reproductive dysfunction is driven by the thyroid deficit, the most appropriate next step is to initiate levothyroxine. This will normalize TRH and prolactin levels, increase SHBG, and typically restore spontaneous ovulation and fertility.

Step-by-Step Solution

1
Analyze the clinical presentation and ultrasound findings.
The patient has secondary amenorrhea, weight gain, fatigue, mild hirsutism, and polycystic ovarian morphology (PCOM).
This constellation of findings strongly mimics Polycystic Ovary Syndrome (PCOS), but requires a review of the endocrine laboratory panel to rule out other etiologies.
2
Interpret the thyroid and prolactin laboratory values.
TSH is markedly elevated and free T4 is low, diagnosing primary hypothyroidism. Prolactin is mildly elevated.
In primary hypothyroidism, the lack of negative feedback from T4 leads to increased thyrotropin-releasing hormone (TRH) from the hypothalamus. TRH stimulates both thyrotrophs (increasing TSH) and lactotrophs (increasing prolactin).
3
Connect the physiological mechanism to the reproductive symptoms.
Elevated prolactin suppresses GnRH pulsatility, leading to anovulation and amenorrhea. Additionally, hypothyroidism decreases hepatic production of sex hormone-binding globulin (SHBG).
Decreased SHBG increases the proportion of unbound, biologically active (free) testosterone, explaining the hirsutism even with a normal total testosterone level. Chronic anovulation leads to the PCOM seen on ultrasound.
4
Determine the next best step in management.
Treat the underlying primary hypothyroidism with levothyroxine.
Restoring euthyroidism will decrease TRH, normalize prolactin, restore normal GnRH pulsatility, and typically resolve the anovulatory infertility without the need for ovulation induction agents.

Key Concept

Primary hypothyroidism can cause a reactive hyperprolactinemia (due to TRH stimulation) and decreased SHBG, creating a clinical picture that perfectly mimics PCOS (amenorrhea, hirsutism, polycystic ovaries).
Estimated Time:2m 0s
Question 167Question →

A 24-year-old woman comes to the clinic for a follow-up visit regarding persistent vaginal discharge and spotting after intercourse. Three weeks ago, she presented with similar symptoms and was diagnosed with cervicitis. A nucleic acid amplification test (NAAT) at that time was positive for *Chlamydia trachomatis* and negative for *Neisseria gonorrhoeae*. She was prescribed a 7-day course of oral doxycycline, which she completed. Her new male sexual partner was also treated, and they abstained from sexual activity for 10 days. Today, her vital signs are within normal limits. Pelvic examination reveals an erythematous, friable cervix with mucopurulent discharge. No cervical motion tenderness or adnexal tenderness is appreciated. A repeat NAAT for *C. trachomatis* and *N. gonorrhoeae* is negative. Wet mount microscopy shows numerous polymorphonuclear leukocytes but no clue cells, trichomonads, or pseudohyphae. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Nucleic acid amplification testing for Mycoplasma genitalium

Answer

Nucleic acid amplification testing for Mycoplasma genitalium
The correct answer is to perform nucleic acid amplification testing (NAAT) for Mycoplasma genitalium. This patient has persistent cervicitis, evidenced by mucopurulent discharge and cervical friability, despite documented compliance with a standard doxycycline regimen for Chlamydia trachomatis. Partner treatment and a negative repeat NAAT make reinfection highly unlikely. In cases of persistent or recurrent cervicitis where Neisseria gonorrhoeae, C. trachomatis, and Trichomonas vaginalis have been ruled out, M. genitalium is the most common causative organism. The Centers for Disease Control and Prevention (CDC) guidelines recommend testing for M. genitalium in all patients with persistent cervicitis or pelvic inflammatory disease (PID). Because M. genitalium has high rates of macrolide resistance, diagnosis must be confirmed via NAAT before initiating specific, targeted therapy (often sequential therapy with doxycycline followed by moxifloxacin or a resistance-guided approach).

Step-by-Step Solution

1
Analyze the patient's initial presentation and treatment.
The patient had confirmed Chlamydia cervicitis and was adequately treated with doxycycline. Her partner was treated, minimizing the risk of reinfection.
Establishing adequate initial treatment helps differentiate treatment failure/reinfection from a new or co-pathogen.
2
Evaluate the current clinical findings and test results.
She has persistent mucopurulent cervicitis. Repeat GC/CT NAAT is negative (ruling out reinfection). Wet mount shows only leukocytes (ruling out Trichomonas and candidiasis).
Negative repeat tests confirm that the initial Chlamydia infection has cleared and points toward an alternative etiology.
3
Determine the most likely etiology for persistent cervicitis.
Mycoplasma genitalium is the most common cause of persistent or recurrent cervicitis and urethritis after standard treatment for Chlamydia.
Current CDC guidelines mandate specific testing for M. genitalium in this clinical scenario.
4
Select the appropriate diagnostic or therapeutic step.
NAAT for Mycoplasma genitalium is the best next step to guide targeted resistance-guided therapy.
Empiric macrolide therapy (azithromycin) is no longer advised due to high resistance rates; confirming the diagnosis first is required for proper antibiotic stewardship.

Key Concept

In women with persistent cervicitis despite appropriate therapy for Chlamydia and Gonorrhea, Mycoplasma genitalium is the most likely pathogen and should be confirmed via NAAT.
Estimated Time:1m 30s
Question 168Question →

A primigravid patient at 3636 weeks gestation comes to the emergency department reporting a 66-hour history of severe, persistent pain in her right upper abdomen accompanied by nausea. The 2929-year-old reports typical fetal movement and no fluid leakage or uterine contractions. Vital signs include a blood pressure of 162/105 mm Hg162/105\text{ mm Hg}, a heart rate of 92/min92/\text{min}, and a temperature of 37.0∘C37.0^\circ\text{C} (98.6∘F98.6^\circ\text{F}). On physical examination, there is noticeable swelling of the hands and face, along with significant tenderness in the right upper abdominal quadrant. The fetal heart rate tracing is Category I, showing a baseline of 145/min145/\text{min}, moderate variability, and positive accelerations.

Laboratory results are as follows:

ParameterResult
Hemoglobin9.8 g/dL9.8\text{ g/dL}
Platelets82,000/mm382,000/\text{mm}^3
Aspartate aminotransferase (AST)145 U/L145\text{ U/L}
Alanine aminotransferase (ALT)130 U/L130\text{ U/L}

Which of the following is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Administration of intravenous magnesium sulfate and induction of labor

Answer

Administration of intravenous magnesium sulfate and induction of labor
The correct approach involves stabilizing the mother with intravenous magnesium sulfate for seizure prophylaxis and promptly proceeding with induction of labor. This patient has HELLP (Hemolysis, Elevated Liver enzymes, Low Platelets) syndrome, a severe variant of preeclampsia. Because she is beyond 34 weeks gestation, immediate delivery is the definitive treatment. A reassuring Category I fetal heart rate tracing indicates that a trial of vaginal delivery is safe and preferred over the surgical risks associated with a cesarean section, especially given her thrombocytopenia.

Step-by-Step Solution

1
Evaluate the patient's clinical presentation and laboratory values.
The combination of right upper quadrant pain, hypertension, thrombocytopenia (82,000/mm382,000/\text{mm}^3), and elevated transaminases establishes the diagnosis of HELLP syndrome.
Accurate diagnosis is required to recognize the severity of the obstetric emergency.
2
Determine the gestational age and fetal status.
The patient is at 3636 weeks gestation, and the fetal heart rate tracing is Category I (reassuring).
Gestational age and fetal stability dictate the timing and mode of delivery.
3
Select the appropriate management strategy based on the diagnosis and gestational age.
Delivery is definitively indicated for HELLP syndrome at ≥34\geq 34 weeks. Magnesium sulfate is administered for seizure prophylaxis, and induction of labor is chosen over cesarean delivery due to reassuring fetal status.
Expediting delivery removes the underlying cause of HELLP syndrome while minimizing surgical risks when possible.

Key Concept

Management of HELLP syndrome at ≥34\geq 34 weeks gestation
Estimated Time:1m 30s
Question 169Question →

A 3434-year-old woman, who has never been pregnant, comes to the physician due to a 44-month history of rapidly progressing facial hair growth and severe acne. Her menstrual periods, previously regular every 2828 days, have completely stopped during this time. The patient has also noted that her voice sounds deeper than usual over the past few weeks. She has no significant past medical history and takes no medications. Her body mass index is 23 kg/m223 \text{ kg/m}^2. Vital signs show a blood pressure of 124/82 mmHg124/82 \text{ mmHg} and a heart rate of 76/min76/\text{min}. Physical examination shows significant terminal hair growth on the chin, upper lip, and chest. Pelvic examination demonstrates clitoromegaly and normal vaginal rugae; bimanual examination reveals a normal-sized uterus, but the adnexa are difficult to palpate.

Laboratory studies show:
- β\beta-hCG: negative
- Prolactin: 14 ng/mL14 \text{ ng/mL} (Normal: <20 ng/mL< 20 \text{ ng/mL})
- Thyroid-stimulating hormone: 2.2 μU/mL2.2 \text{ } \mu\text{U/mL}
- Total testosterone: 210 ng/dL210 \text{ ng/dL} (Normal: 15−70 ng/dL15-70 \text{ ng/dL})
- Dehydroepiandrosterone sulfate (DHEAS): 2.5 μg/mL2.5 \text{ } \mu\text{g/mL} (Normal: 0.5−4.0 μg/mL0.5-4.0 \text{ } \mu\text{g/mL})

Which of the following is the most appropriate next step in the evaluation of this patient?

Show answer & explanation

Answer: Pelvic ultrasonography

Answer

Pelvic ultrasonography
This patient's rapid onset of frank virilization (clitoromegaly, deepening voice) combined with a markedly elevated serum testosterone level (>150 ng/dL> 150 \text{ ng/dL}) is highly suspicious for an androgen-secreting tumor. To localize the tumor, one must look at the specific androgen profile. In women, testosterone is primarily secreted by the ovaries, while dehydroepiandrosterone sulfate (DHEAS) is almost exclusively produced by the adrenal glands. Because this patient has a normal DHEAS level but extremely high testosterone, the excess androgen is of ovarian origin (e.g., a Sertoli-Leydig cell tumor). Therefore, the most appropriate next step is to evaluate the ovaries using pelvic ultrasonography.

Step-by-Step Solution

1
Identify the clinical syndrome from the patient's presentation.
The patient presents with rapid-onset (44 months) virilization, evidenced by clitoromegaly and voice deepening, which is highly concerning for an androgen-secreting neoplasm.
Differentiating between benign hyperandrogenism (like PCOS, which is slow-onset and mild) and neoplastic hyperandrogenism (which is rapid and severe) dictates the urgency and direction of the workup.
2
Analyze the laboratory results to localize the source of excess androgens.
Total testosterone is markedly elevated (210 ng/dL210 \text{ ng/dL}, typically >150 ng/dL>150 \text{ ng/dL} in tumors), while DHEAS is within normal limits.
Testosterone is primarily produced by the ovaries, whereas DHEAS is almost exclusively produced by the adrenal glands. This laboratory profile isolates the ovaries as the source of the hyperandrogenism.
3
Determine the next best diagnostic step based on the localized source.
Pelvic ultrasonography is chosen to visualize the ovaries and confirm the presence of a mass.
Since the labs point to an ovarian source (like a Sertoli-Leydig cell tumor), direct imaging of the pelvis is the most appropriate next step.

Key Concept

Patients with rapid-onset virilization and markedly elevated testosterone with normal DHEAS should undergo pelvic ultrasonography to evaluate for an ovarian androgen-secreting tumor.
Estimated Time:1m 15s
Question 170Question →

An obstetric rapid response is called for a patient at 36 weeks36\text{ weeks} of gestation who presents to the triage unit with a 2-day2\text{-day} history of worsening jaundice, persistent nausea, and severe lethargy. She has no significant past medical history, and her prenatal course was previously unremarkable. Upon evaluation, she appears visibly confused and is difficult to arouse. Her temperature is 37.0∘C37.0^\circ\text{C} (98.6∘F98.6^\circ\text{F}), blood pressure is 132/84 mm Hg132/84\text{ mm Hg}, and heart rate is 108/min108/\text{min}. Physical examination reveals scleral icterus and right upper quadrant abdominal tenderness. The uterus is soft, and pelvic examination shows a closed cervix. A continuous fetal monitor is placed, demonstrating a baseline heart rate of 145/min145/\text{min} with moderate variability and spontaneous accelerations; there are no decelerations.

Initial laboratory studies are obtained and reveal the following:

Hemoglobin: 10.8 g/dL10.8\text{ g/dL}
Platelet count: 88,000/mm388,000/\text{mm}^3
Leukocyte count: 16,500/mm316,500/\text{mm}^3
Glucose: 42 mg/dL42\text{ mg/dL}
Aspartate aminotransferase (AST): 740 U/L740\text{ U/L}
Alanine aminotransferase (ALT): 820 U/L820\text{ U/L}
Total bilirubin: 5.6 mg/dL5.6\text{ mg/dL}
Creatinine: 1.8 mg/dL1.8\text{ mg/dL}
Prothrombin time: 22 seconds22\text{ seconds} (Reference: 11−14 seconds11-14\text{ seconds})
Activated partial thromboplastin time: 54 seconds54\text{ seconds} (Reference: 25−40 seconds25-40\text{ seconds})

Intravenous dextrose is immediately administered, and the patient becomes fully oriented. Blood products are typed and crossmatched. Which of the following is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Induction of labor

Answer

Induction of labor
The patient's clinical picture is classic for Acute Fatty Liver of Pregnancy (AFLP), a rare but catastrophic complication typically occurring in the third trimester. It is characterized by microvesicular steatosis leading to acute liver failure. The hallmark laboratory abnormalities that distinguish AFLP from HELLP syndrome are profound hypoglycemia, elevated ammonia levels, and significant coagulopathy (prolonged PT and aPTT). The definitive treatment for AFLP is immediate delivery after initial maternal stabilization (e.g., glucose administration and ordering blood products). Because the fetal heart tracing is reassuring (Category I) and the patient has profound coagulopathy, induction of labor is the preferred route of delivery. Performing a laparotomy (cesarean delivery) on a patient with severe coagulopathy carries an unacceptably high risk of exsanguination and should be reserved only for obstetric indications or fetal distress.

Step-by-Step Solution

1
Analyze the clinical presentation and laboratory values to establish the underlying diagnosis.
The patient has 3rd-trimester jaundice, altered mental status, profound hypoglycemia (42 mg/dL42\text{ mg/dL}), and severe coagulopathy (prolonged PT and aPTT).
These specific findings distinguish Acute Fatty Liver of Pregnancy (AFLP) from severe preeclampsia and HELLP syndrome (which typically feature normal glucose and normal coagulation times).
2
Determine the definitive treatment requirement for the established diagnosis.
AFLP is rapidly fatal for both mother and fetus if the pregnancy continues; immediate delivery is required once the mother is stabilized.
The microvesicular fatty infiltration of the liver is driven by a maternal-fetal defect in fatty acid metabolism, which only resolves upon delivery of the placenta.
3
Evaluate fetal status and maternal surgical risk to select the optimal mode of delivery.
The fetal heart tracing is Category I (reassuring), and the mother has severe, life-threatening coagulopathy.
Because there is no fetal indication for operative delivery, and major abdominal surgery (cesarean) carries an extreme risk of exsanguination due to the coagulopathy, vaginal delivery via induction of labor is the preferred next best step.

Key Concept

Diagnosis and acute management of Acute Fatty Liver of Pregnancy (AFLP), prioritizing vaginal delivery due to coagulopathy.
Question 171Question →

Paramedics bring a 3030-year-old patient at 3737 weeks of pregnancy to the trauma bay after a severe motor vehicle collision. Her obstetric history is notable for one prior uncomplicated vaginal delivery at term. She complains of unrelenting, severe lower abdominal pain and reports a small amount of dark red vaginal bleeding.

Vital signs show a blood pressure of 86/5286/52 mmHg, a heart rate of 128128/min, and a respiratory rate of 2222/min. Physical examination reveals a rigid, board-like uterus that is extremely tender to palpation. Pelvic examination demonstrates the cervix is 11 cm dilated and 50%50\% effaced.

Continuous fetal heart rate monitoring displays a baseline of 105105/min with absent beat-to-beat variability and recurrent late decelerations occurring with every spontaneous uterine contraction. Laboratory analysis reveals a hemoglobin of 9.29.2 g/dL and a normal platelet count.

Which of the following is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Commence aggressive intravenous fluid resuscitation and transfer immediately for operative delivery

Answer

The most appropriate next step is to commence aggressive intravenous fluid resuscitation and transfer the patient immediately for operative delivery.
The patient's presentation of a rigid, tender uterus, dark vaginal bleeding, and hemorrhagic shock following blunt abdominal trauma is highly characteristic of a severe placental abruption. The shearing forces of the motor vehicle collision have caused premature separation of the placenta. This disruption in uteroplacental perfusion has led to severe fetal hypoxia, evidenced by the Category III fetal heart rate tracing (absent variability with recurrent late decelerations). In the setting of maternal hemodynamic instability and a non-reassuring fetal status, the most appropriate management is simultaneous aggressive maternal volume resuscitation (using intravenous fluids and blood products) and immediate operative delivery (cesarean delivery). Delaying intervention for imaging or attempting to prolong the pregnancy risks both maternal exsanguination and fetal demise.

Step-by-Step Solution

1
Evaluate the patient's hemodynamic status following blunt abdominal trauma.
The patient exhibits severe hypotension (86/5286/52 mmHg) and tachycardia (128128/min), indicating hemorrhagic shock.
Trauma in pregnancy requires simultaneous assessment of maternal stability and fetal well-being, with maternal stabilization being the absolute priority.
2
Identify the most likely obstetric cause for the clinical presentation.
The combination of trauma, a rigid and tender uterus, dark vaginal bleeding, and maternal shock strongly indicates a severe placental abruption.
Blunt trauma can cause shearing forces that prematurely detach the placenta from the uterine wall, leading to significant concealed or visible hemorrhage.
3
Analyze the fetal heart rate tracing to determine fetal status.
A baseline of 105105/min with absent variability and recurrent late decelerations constitutes a Category III tracing.
Placental abruption disrupts uteroplacental blood flow, resulting in severe fetal hypoxia and acidemia, manifested as a Category III tracing.
4
Determine the definitive next best step in management.
Immediate aggressive intravenous fluid and blood product resuscitation alongside emergency surgical delivery are mandated.
Maternal hemodynamic instability and a Category III fetal heart tracing require immediate operative intervention without delaying for imaging or attempting vaginal delivery.

Key Concept

Management of placental abruption with maternal hemodynamic instability and fetal distress
Question 172Question →

A 3232-year-old female, currently in her second pregnancy (G2P1) at 3434 weeks of gestation, is evaluated in the emergency department for shortness of breath and leg swelling. She states that the breathlessness has gradually developed over the past few weeks and is most noticeable when she lies flat in bed. She denies chest pain, cough, or pain in her legs. Her medical history is unremarkable, and her pregnancy has been uncomplicated.

Vital signs show a temperature of 37.1∘C37.1^\circ\text{C} (98.8∘F98.8^\circ\text{F}), blood pressure of 112/70 mmHg112/70\text{ mmHg}, pulse of 86/min86\text{/min}, and respirations of 16/min16\text{/min}. Oxygen saturation is 99%99\% on ambient air.

Physical examination demonstrates 1+ symmetric, bilateral pitting edema extending to the ankles. The maximum circumference of the right calf is 35.0 cm35.0\text{ cm} and the left calf is 35.5 cm35.5\text{ cm}. Cardiac auscultation reveals a grade 2/6 early systolic murmur at the left sternal border. The lungs are clear to auscultation bilaterally.

Laboratory analysis reveals the following:

Hemoglobin: 10.6 g/dL10.6\text{ g/dL}
Platelet count: 145,000/mm3145,000\text{/mm}^3
D-dimer: 920 ng/mL920\text{ ng/mL} (Reference: <500 ng/mL< 500\text{ ng/mL})

Arterial blood gas analysis on ambient air:
pH: 7.447.44
PaO 2_2: 104 mmHg104\text{ mmHg}
PaCO 2_2: 29 mmHg29\text{ mmHg}
HCO 3−_3^-: 19 mEq/L19\text{ mEq/L}

Which of the following is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Reassurance and routine obstetric follow-up

Answer

Reassurance and routine obstetric follow-up
The correct answer is reassurance and routine obstetric follow-up because this patient's clinical and laboratory findings entirely represent normal physiologic adaptations to pregnancy. Progesterone directly stimulates the medullary respiratory center, increasing minute ventilation (primarily via increased tidal volume) and resulting in a chronic, compensated respiratory alkalosis (pH slightly alkalotic, low PaCO 2_2, and a compensatory decrease in HCO 3−_3^-). The growing uterus elevates the diaphragm, which can cause a subjective feeling of breathlessness, particularly when supine. Additionally, normal pregnancy is a hypercoagulable state with physiologically increased D-dimer levels; therefore, a D-dimer test has virtually no negative predictive value in the third trimester. Her symmetric edema and grade 2/6 systolic ejection murmur are expected consequences of increased plasma volume and cardiac output. Since she lacks acute or focal signs of pathology (such as tachycardia, hypoxia, asymmetric leg swelling, or hypertension), reassurance is the most appropriate management.

Step-by-Step Solution

1
Analyze the patient's presenting symptoms and vital signs.
The patient reports a gradual onset of dyspnea and orthopnea, with symmetric leg swelling. Vital signs are strictly within normal limits, including normal oxygen saturation and heart rate.
Establishing the acuity of the presentation helps differentiate between life-threatening emergencies (e.g., pulmonary embolism) and physiologic changes of the third trimester.
2
Evaluate the physical examination findings.
Symmetric bilateral pitting edema and a 2/6 early systolic flow murmur are present. Lungs are clear, and there is no asymmetric calf swelling.
These findings are classic normal physiological adaptations driven by venous compression from the gravid uterus and increased maternal blood volume/cardiac output.
3
Interpret the laboratory and arterial blood gas (ABG) results in the context of pregnancy.
The patient has a primary respiratory alkalosis with metabolic compensation (pH 7.447.44, low PaCO 2_2, low HCO 3−_3^-). The D-dimer is elevated, and mild dilutional anemia is present.
Progesterone directly stimulates the medullary respiratory center, increasing minute ventilation and causing a chronic respiratory alkalosis. D-dimer naturally rises during normal pregnancy, rendering it useless for ruling out venous thromboembolism.
4
Synthesize the findings to determine the correct management.
Because all findings reflect normal pregnancy physiology and the patient has a Wells score of zero, no further diagnostic testing or treatment is indicated.
Empiric treatment or advanced imaging based on physiologically expected abnormal laboratory values leads to unnecessary healthcare interventions and patient anxiety.

Key Concept

Normal physiologic adaptations in the third trimester include dyspnea, symmetric lower extremity edema, systolic flow murmurs, physiologically elevated D-dimer levels, and a compensated primary respiratory alkalosis.
Question 173Question →

A primigravid patient at 3737 weeks of gestation is currently in the labor and delivery unit. She was admitted 2424 hours ago for induction of labor due to preeclampsia with severe features. She is receiving continuous intravenous oxytocin, labetalol, and magnesium sulfate. Over the past 44 hours, her total urine output has been 45 mL45\text{ mL}. The nurse calls the physician because the patient has become increasingly somnolent and difficult to arouse. Current vital signs are temperature 37.1∘C37.1^\circ\text{C} (98.8∘F98.8^\circ\text{F}), blood pressure 135/85 mmHg135/85\text{ mmHg}, pulse 82/min82/\text{min}, and respiratory rate 8/min8/\text{min}. Oxygen saturation is 90%90\% on room air. Neurologic examination reveals absent deep tendon reflexes at the patella and biceps. The continuous fetal heart rate tracing demonstrates a baseline of 145/min145/\text{min}, minimal variability, and no decelerations. Which of the following is the most appropriate initial step in management?

Show answer & explanation

Answer: Discontinue the magnesium sulfate infusion and administer intravenous calcium gluconate

Answer

Discontinue the magnesium sulfate infusion and administer intravenous calcium gluconate
This patient has severe magnesium toxicity, characterized by absent deep tendon reflexes, somnolence, and severe respiratory depression (respiratory rate of 8/min8/\text{min}). Magnesium sulfate is exclusively excreted by the kidneys; therefore, her marked oliguria led to decreased clearance and toxic accumulation. The most appropriate initial step is to immediately discontinue the magnesium sulfate infusion and administer intravenous calcium gluconate, which antagonizes the effects of magnesium at the neuromuscular junction and reverses respiratory depression.

Step-by-Step Solution

1
Evaluate the patient's neurologic and respiratory status.
The patient is somnolent with absent deep tendon reflexes, a respiratory rate of 8/min, and hypoxia.
To rapidly identify life-threatening central nervous system and respiratory depression.
2
Correlate the clinical presentation with current medications and risk factors.
The patient is receiving magnesium sulfate and has oliguria (45 mL over 4 hours).
Magnesium is excreted exclusively by the kidneys. Oliguria leads to rapid accumulation of magnesium, causing toxicity (areflexia followed by respiratory depression).
3
Determine the most appropriate initial intervention.
Stop the magnesium infusion and administer the antidote, calcium gluconate.
Calcium competitively antagonizes magnesium at the neuromuscular junction, reversing the life-threatening respiratory depression and stabilizing the myocardium.

Key Concept

Patients with preeclampsia receiving magnesium sulfate who develop oliguria are at high risk for magnesium toxicity, which presents sequentially as loss of deep tendon reflexes, somnolence, and respiratory depression. Management requires immediate cessation of the infusion and administration of intravenous calcium gluconate.
Question 174Question →

During a routine health maintenance visit, a 54-year-old G2P2 patient reports experiencing two days of light vaginal spotting the previous week. She underwent natural menopause at age 51. Her past medical history is significant for estrogen receptor-positive, node-negative breast cancer, for which she was treated with a lumpectomy and radiation therapy three years ago. Since completing her primary surgical and radiation treatment, she has been maintained on tamoxifen. Her body mass index is 26 kg/m^2. Vital signs are within normal limits. Pelvic examination demonstrates normal external genitalia, a small and mobile uterus, and no palpable adnexal masses. Speculum examination shows a small amount of dark red blood in the vaginal vault, but no active bleeding or visible cervical lesions. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Endometrial biopsy

Answer

Endometrial biopsy
The correct answer is endometrial biopsy. This patient presents with postmenopausal bleeding, which is abnormal and should always trigger an evaluation for endometrial cancer. Her risk is further elevated by her use of tamoxifen. Tamoxifen is a selective estrogen receptor modulator (SERM) that acts as an estrogen antagonist in breast tissue but as an estrogen agonist in the uterus. This agonistic effect promotes endometrial proliferation, increasing the risk of endometrial polyps, hyperplasia, and adenocarcinoma. The standard of care for postmenopausal bleeding is evaluation with either a transvaginal ultrasound or an endometrial biopsy. In a patient on tamoxifen, transvaginal ultrasound is often less useful because tamoxifen frequently causes subepithelial stromal hypertrophy, resulting in a falsely thickened endometrial stripe on imaging. Therefore, direct tissue sampling via endometrial biopsy is the most definitive and appropriate next step to rule out malignancy.

Step-by-Step Solution

1
Identify the primary clinical problem and demographic risk factors.
The patient is a postmenopausal woman presenting with new-onset vaginal bleeding.
Postmenopausal bleeding is the cardinal symptom of endometrial cancer and requires immediate evaluation.
2
Analyze the impact of the patient's past medical history and medication use.
The patient takes tamoxifen for breast cancer, which acts as an estrogen agonist on the endometrium.
Tamoxifen significantly increases the risk of endometrial hyperplasia and endometrial adenocarcinoma.
3
Determine the most appropriate diagnostic intervention based on the clinical presentation.
Endometrial tissue sampling is required.
Because the risk of malignancy is high, direct histologic evaluation of the endometrium via biopsy is the standard of care to definitively rule in or rule out cancer.

Key Concept

Postmenopausal bleeding in a patient taking tamoxifen requires prompt evaluation with an endometrial biopsy to rule out endometrial hyperplasia or adenocarcinoma.
Question 175Question →

An obstetric team is attending the delivery of a macrosomic infant at 40 weeks gestation. After the fetal head emerges, it immediately retracts tightly against the mother's perineum. The anterior shoulder remains impacted behind the pubic symphysis despite routine gentle downward traction. Arrange the following management steps in the correct standard sequence of escalation to resolve this complication, from the immediate first response to the maneuver of last resort.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is: 1) Call for assistance and instruct the mother to stop pushing, 2) Perform the McRoberts maneuver with suprapubic pressure, 3) Execute internal rotational maneuvers, 4) Perform the Zavanelli maneuver as a last resort.
The widely established protocol for managing shoulder dystocia involves a clear stepwise progression from least invasive to most invasive. The clinician must first recognize the emergency, halt pushing, and mobilize help. The initial physical intervention is the McRoberts maneuver (often coupled with suprapubic pressure), which safely alters maternal pelvic geometry. If external maneuvers fail, the provider escalates to internal vaginal maneuvers (such as the Woods corkscrew or delivering the posterior arm) to manually alter the fetal position. Heroic measures, such as replacing the fetal head to facilitate an emergent cesarean section (Zavanelli maneuver), are strictly reserved for intractable cases where all other maneuvers have failed.

Step-by-Step Solution

1
Identify the clinical presentation as shoulder dystocia.
The retraction of the fetal head against the perineum (turtle sign) confirms the anterior shoulder is impacted behind the maternal pubic symphysis.
Immediate recognition is required to initiate a standardized management protocol and prevent hypoxic injury to the fetus.
2
Determine the initial, non-physical response.
The provider must tell the patient to stop pushing and immediately call for help.
Pushing worsens the impaction. Resolving the dystocia requires a coordinated team (e.g., an assistant to apply suprapubic pressure while the primary provider performs maneuvers).
3
Identify the first-line physical maneuvers.
McRoberts maneuver combined with suprapubic pressure should be performed first.
These external maneuvers alter the maternal pelvic geometry and are successful in relieving a large percentage of shoulder dystocias without requiring internal vaginal manipulation.
4
Identify the secondary interventions if first-line maneuvers fail.
Internal rotational maneuvers (e.g., Woods corkscrew, Rubin) or delivery of the posterior arm are the next steps.
Internal maneuvers directly alter the orientation of the fetal shoulders to bypass the bony obstruction.
5
Identify the maneuver of last resort.
The Zavanelli maneuver (replacing the fetal head into the pelvis to perform a cesarean section) is the final escalation.
Because of significant maternal and fetal morbidity, heroic measures are strictly reserved for cases refractory to all other standard maneuvers.

Key Concept

The management of shoulder dystocia follows a strict, standardized escalation protocol (e.g., HELPERR mnemonic) that begins with calling for help and using noninvasive external maneuvers, progresses to invasive internal maneuvers, and concludes with heroic measures as a last resort.
Question 176Question →

An adolescent primigravida at 39 weeks gestation is currently in the active phase of labor following spontaneous rupture of membranes 24 hours ago. Over the last hour, she has developed a new-onset fever. She is currently receiving continuous epidural analgesia. Her temperature is 39.2°C (102.6°F), blood pressure is 112/70 mm Hg, pulse is 115/min, and respirations are 18/min. Physical examination reveals a uterus that is tender to palpation between contractions. Pelvic examination shows the cervix is 6 cm dilated and 90% effaced, with the fetal presenting part at +1 station. Uterine contractions are occurring every 5 to 6 minutes. Continuous fetal monitoring displays a baseline heart rate of 175/min with moderate variability and occasional early decelerations. Which of the following is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Intravenous ampicillin, gentamicin, and oxytocin

Answer

The correct answer is the administration of intravenous ampicillin, gentamicin, and oxytocin.
The correct answer combines both the necessary medical treatment and the appropriate obstetric management. The patient has clinical intra-amniotic infection (fever, fetal tachycardia, uterine tenderness) occurring after prolonged rupture of membranes. Standard treatment includes broad-spectrum antibiotics (such as ampicillin and gentamicin). Additionally, because her contractions are inadequate (every 5-6 minutes in the active phase) and the fetal heart rate tracing is reassuring (Category I/II with moderate variability and early decelerations), the most appropriate obstetric step is to expedite vaginal delivery via oxytocin augmentation. Intra-amniotic infection alone is not an indication for cesarean delivery.

Step-by-Step Solution

1
Diagnose the underlying condition based on maternal vital signs and physical examination.
The maternal temperature of 39.2°C (102.6°F), accompanied by uterine tenderness and fetal tachycardia, confirms the diagnosis of intra-amniotic infection (chorioamnionitis).
Maternal fever greater than 39.0°C in labor, especially with prolonged rupture of membranes and additional infectious signs, meets the criteria for clinical intra-amniotic infection.
2
Select the appropriate pharmacologic intervention for the infection.
Intravenous broad-spectrum antibiotics, typically ampicillin and gentamicin, are required.
Prompt antibiotic administration prevents maternal morbidity (e.g., sepsis) and neonatal infectious complications.
3
Determine the appropriate obstetric management by evaluating labor progression and fetal status.
The contractions are inadequate (every 5-6 minutes) for the active phase of labor, and the fetal heart rate tracing is reassuring (moderate variability, no late/variable decelerations). Therefore, labor augmentation with oxytocin is indicated.
Intra-amniotic infection requires expeditious delivery. Because the fetus is tolerating labor well, vaginal delivery should be facilitated with oxytocin rather than proceeding to an unnecessary cesarean delivery.

Key Concept

Intra-amniotic infection (chorioamnionitis) is managed with broad-spectrum antibiotics and augmentation of labor to expedite vaginal delivery; it is not an absolute indication for cesarean delivery.
Question 177Question →

A 30-year-old nulliparous woman at 40 weeks and 1 day of gestation is managed on the labor unit. She was admitted 8 hours ago in spontaneous active labor. Four hours ago, her cervical examination revealed 6 cm dilation, 100% effacement, and 0 station. Spontaneous rupture of membranes occurred around that time, and the amniotic fluid was clear. An intrauterine pressure catheter was subsequently placed. Over the last four hours, she has consistently had 4 to 5 uterine contractions every 10 minutes, generating a total of 240 to 260 Montevideo units. Re-evaluation of her cervix just now shows no change from the prior examination. The maternal vital signs are within normal limits. The fetal heart rate tracing exhibits a baseline of 140/min, moderate baseline variability, the presence of accelerations, and no decelerations. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Cesarean delivery

Answer

Cesarean delivery
The correct answer is cesarean delivery. This patient has reached the active phase of labor (defined as cervical dilation of ≥ 6 cm) and has subsequently experienced an arrest of dilation. According to clinical guidelines, active phase arrest is diagnosed in a patient with ruptured membranes when there is no cervical change for 4 or more hours despite adequate uterine contractions (defined as > 200 Montevideo units in a 10-minute period), or for 6 or more hours if contractions are inadequate. This patient has had no cervical change for 4 hours while consistently generating 240 to 260 Montevideo units. Once active phase arrest is diagnosed, the most appropriate management is to proceed with a cesarean delivery.

Step-by-Step Solution

1
Evaluate cervical dilation progress over time.
The cervix has remained at 6 cm for 4 hours.
To determine if labor is progressing normally or if there is an arrest of dilation.
2
Assess the adequacy of uterine contractions.
Contractions are consistently generating 240 to 260 Montevideo units (adequate is > 200).
To distinguish between protraction (where oxytocin would be indicated) and arrest (where cesarean is indicated).
3
Apply the diagnostic criteria for active phase arrest.
The patient meets the criteria: ≥ 6 cm dilation, ruptured membranes, and no change for ≥ 4 hours with adequate contractions.
To form a definitive diagnosis and determine the next best step in management.
4
Determine the appropriate intervention for active phase arrest.
Cesarean delivery is selected.
Once active phase arrest is confirmed, cesarean delivery is the standard of care to prevent maternal and fetal morbidity.

Key Concept

Active phase arrest of labor is diagnosed when a patient at ≥ 6 cm dilation with ruptured membranes has no cervical change for ≥ 4 hours with adequate contractions (> 200 Montevideo units) or ≥ 6 hours with inadequate contractions; it is an absolute indication for cesarean delivery.
Question 178Question →

A 22-year-old female is evaluated in the emergency department for three days of worsening right-sided abdominal pain and lower pelvic discomfort. The abdominal pain is sharp, exacerbated by deep inspiration, and accompanied by nausea. She has a past medical history of asthma and a severe allergic reaction to amoxicillin during childhood that resulted in anaphylaxis and endotracheal intubation. Her temperature is 38.9°C (102.0°F), blood pressure is 112/72 mmHg, and pulse is 114/min. Physical examination reveals right upper quadrant tenderness with a palpable friction rub over the anterior costal margin, as well as profound bilateral lower abdominal tenderness. Pelvic examination demonstrates a friable cervix with mucopurulent discharge at the cervical os and exquisite pain on cervical motion. Laboratory studies show a leukocyte count of 16,800/mm³. Liver aminotransferases and alkaline phosphatase levels are within normal limits. A right upper quadrant ultrasound demonstrates no biliary abnormalities and no pericholecystic fluid. Which of the following is the most appropriate initial pharmacologic management for this patient?

Show answer & explanation

Answer: Intravenous clindamycin and intravenous gentamicin

Answer

Intravenous clindamycin and intravenous gentamicin
This patient requires inpatient management for severe pelvic inflammatory disease (PID) complicated by perihepatitis (Fitz-Hugh-Curtis syndrome), indicated by high fever, severe right upper quadrant pain exacerbated by inspiration, and a hepatic friction rub with normal liver enzymes. Due to her history of amoxicillin-induced anaphylaxis requiring intubation, all beta-lactam antibiotics—including penicillins, cephalosporins (like ceftriaxone), and cephamycins (like cefoxitin)—must be avoided. The standard first-line alternative parenteral regimen that provides appropriate coverage against Chlamydia trachomatis, Neisseria gonorrhoeae, anaerobes, and gram-negative rods without utilizing beta-lactams is intravenous clindamycin and intravenous gentamicin.

Step-by-Step Solution

1
Diagnose the primary clinical syndrome from pelvic findings.
Pelvic Inflammatory Disease (PID)
The patient has lower abdominal pain, cervical motion tenderness, and mucopurulent cervical discharge.
2
Identify the cause of the pleuritic right upper quadrant pain.
Fitz-Hugh-Curtis syndrome (perihepatitis)
The combination of severe right upper quadrant pain with a hepatic friction rub, normal liver enzymes, and a normal biliary ultrasound in the setting of PID strongly indicates inflammation of the liver capsule and surrounding peritoneum.
3
Determine the appropriate setting for treatment.
Inpatient admission with parenteral (IV) therapy
The patient is highly febrile (38.9°C), systemically ill, and has complicated PID with perihepatitis, which meets standard criteria for hospital admission.
4
Select the appropriate pharmacologic regimen accounting for the patient's medical history.
Intravenous clindamycin and intravenous gentamicin
The patient's history of anaphylaxis and intubation due to amoxicillin constitutes a severe IgE-mediated type 1 hypersensitivity. All beta-lactams, including cephalosporins and cephamycins, must be avoided. Clindamycin plus gentamicin is the primary recommended non-beta-lactam inpatient regimen.

Key Concept

Management of severe, complicated pelvic inflammatory disease (PID) requiring inpatient therapy in the setting of severe beta-lactam anaphylaxis.
Question 179Question →

A 32-year-old woman, gravida 2, para 2, experiences sudden, massive vaginal bleeding shortly after a spontaneous vaginal delivery at 39 weeks gestation. The placenta delivered spontaneously 5 minutes ago with gentle cord traction. Her blood pressure is 78/40 mmHg and her pulse is 135/min. On physical examination, the uterine fundus cannot be palpated in the abdomen. Pelvic examination reveals a red, fleshy, globular mass protruding through the external cervical os. Arrange the following management steps in the correct sequential order for this patient's condition.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence for managing acute uterine inversion is: 1) Discontinue the ongoing oxytocin infusion, 2) Attempt immediate manual replacement of the uterus, 3) Administer a uterine relaxing agent (e.g., nitroglycerin) if initial replacement fails, and 4) Restart uterotonic medications (e.g., oxytocin) after successful replacement.
Acute uterine inversion is an obstetric emergency presenting with an absent uterine fundus, a vaginal mass, and profound hemorrhagic shock. The first priority in management is to stop all uterotonics (e.g., oxytocin) to prevent the uterus from contracting in the inverted state. Second, prompt manual replacement is attempted by pushing the fundus back up through the cervix. Third, if the uterus is incarcerated by a contracted lower segment and initial replacement fails, uterine relaxants (e.g., nitroglycerin, terbutaline, or general anesthetics) are administered to facilitate replacement. Finally, once normal anatomy is successfully restored, uterotonics must be immediately restarted to ensure the uterus contracts and stays in place, which also serves to halt the hemorrhage.

Step-by-Step Solution

1
Discontinue uterotonics
Halts further uterine contraction.
A contracting inverted uterus becomes incarcerated by the cervical ring and cannot be manually replaced.
2
Perform manual replacement
Restores normal uterine anatomy.
Immediate replacement by pushing the fundus upward through the cervix is highly successful if done before significant edema forms.
3
Administer uterine relaxant
Relaxes the lower uterine segment.
This is necessary only if the initial manual attempt is unsuccessful due to a tight cervical contraction ring.
4
Restart uterotonics
Maintains uterine tone in its normal anatomic position.
Prevents reinversion and controls ongoing postpartum hemorrhage by compressing uterine blood vessels.

Key Concept

Management Sequence for Acute Uterine Inversion
Question 180Question →

A 64-year-old female presents to the gynecology clinic evaluating intermittent vaginal bleeding that has been ongoing for the past two months. She notes that the bleeding is particularly noticeable after intercourse. She reached menopause at age 52 and takes no medications. Her last gynecologic examination and cervical cancer screening were over two decades ago. Vital signs are within normal limits. Speculum examination reveals a 3.5-cm friable, ulcerated mass on the anterior lip of the cervix that bleeds on contact. Bimanual examination demonstrates a normal-sized, mobile uterus with no adnexal masses. A transvaginal ultrasound shows an endometrial stripe of 2.5 mm. Which of the following is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Biopsy of the visible cervical lesion

Answer

Biopsy of the visible cervical lesion
The correct response is to biopsy the visible cervical lesion. This patient's presentation of postcoital and postmenopausal bleeding, combined with a lack of regular screening and a 3.5-cm friable, ulcerated cervical mass, is highly suspicious for invasive cervical carcinoma. Any gross, exophytic, or ulcerated cervical lesion must be biopsied directly to establish a histologic diagnosis. Once the diagnosis of cervical cancer is confirmed, the patient will undergo staging (often clinical or with advanced imaging like PET/CT) to determine if she is a candidate for radical surgery (e.g., radical hysterectomy) or primary chemoradiation.

Step-by-Step Solution

1
Analyze the patient's presentation and demographics.
A 64-year-old postmenopausal woman without recent screening presents with postcoital bleeding.
Establishing the patient's risk profile for gynecologic malignancies.
2
Evaluate the physical examination and imaging findings.
A 3.5-cm friable, ulcerated cervical mass is present. Ultrasound shows a normal, thin endometrium (2.5 mm).
To localize the source of the bleeding and identify the primary pathology.
3
Determine the most appropriate next step in management.
The correct action is to obtain a tissue biopsy directly from the cervical mass.
A macroscopic, suspicious lesion requires direct histologic diagnosis to guide further staging and treatment.

Key Concept

Patients presenting with postmenopausal or postcoital bleeding and a gross, clinically suspicious cervical lesion require direct biopsy of the lesion rather than screening cytology or endometrial evaluation.
PreviousPage 9 / 53Next
Obstetrics and Gynecology Practice Questions — USMLE Step 2 CK — Page 9 | Examkin